Mission Wealth Management LP boosted its stake in Waters Co. (NYSE:WAT) by 6.0% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 1,415 shares of the medical instruments supplier’s stock after purchasing an additional 80 shares during the period. Mission Wealth Management LP’s holdings in Waters were worth $356,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of WAT. Athena Capital Advisors LLC acquired a new stake in Waters in the 4th quarter valued at approximately $28,000. Lindbrook Capital LLC acquired a new stake in Waters in the 4th quarter valued at approximately $41,000. Massey Quick Simon & CO. LLC acquired a new stake in Waters in the 1st quarter valued at approximately $43,000. Van ECK Associates Corp increased its holdings in Waters by 33.8% in the 4th quarter. Van ECK Associates Corp now owns 297 shares of the medical instruments supplier’s stock valued at $56,000 after purchasing an additional 75 shares during the last quarter. Finally, Enlightenment Research LLC acquired a new stake in Waters in the 4th quarter valued at approximately $57,000. Hedge funds and other institutional investors own 92.63% of the company’s stock.
NYSE:WAT opened at $203.20 on Friday. The firm has a market capitalization of $14.12 billion, a price-to-earnings ratio of 24.51, a price-to-earnings-growth ratio of 2.14 and a beta of 1.08. The company has a debt-to-equity ratio of 1.15, a current ratio of 3.44 and a quick ratio of 2.89. Waters Co. has a 52 week low of $167.93 and a 52 week high of $255.21.
WAT has been the subject of several research reports. Robert W. Baird dropped their price target on shares of Waters from $211.00 to $209.00 and set a “neutral” rating for the company in a research note on Wednesday, April 24th. ValuEngine downgraded shares of Waters from a “buy” rating to a “hold” rating in a research note on Wednesday, April 24th. Barclays dropped their price target on shares of Waters from $218.00 to $210.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 24th. UBS Group dropped their price target on shares of Waters from $248.00 to $230.00 and set a “neutral” rating for the company in a research note on Wednesday, April 24th. Finally, Cleveland Research downgraded shares of Waters from a “neutral” rating to an “underperform” rating in a research note on Wednesday. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $208.71.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://www.baseballdailydigest.com/news/2019/06/16/mission-wealth-management-lp-boosts-position-in-waters-co-nysewat.html.
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Article: Marijuana Stocks Investing Considerations
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.